Achieve Life Sciences (ACHV) News Today $2.68 -0.07 (-2.55%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$2.70 +0.02 (+0.93%) As of 07/18/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACHV Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Should You Hold Achieve Life Sciences (ACHV)? - Insider MonkeyJuly 8, 2025 | insidermonkey.comAchieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking CessationJuly 7, 2025 | seekingalpha.comAchieve Life Sciences, Inc. (ACHV) - Yahoo FinanceJuly 5, 2025 | finance.yahoo.comAchieve Life Sciences (ACHV) Receives a Buy from Raymond JamesJuly 4, 2025 | theglobeandmail.comAchieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional SecuritiesJune 30, 2025 | globenewswire.comAchieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation - MorningstarJune 28, 2025 | morningstar.comMAchieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two ...June 28, 2025 | morningstar.comMAchieve Life Sciences Submits New Drug Application for Cytisinicline to Treat Nicotine Dependence in Adults - NasdaqJune 28, 2025 | nasdaq.comAchieve Life Sciences Shares Fall on $3 Underwritten Offering PriceJune 27, 2025 | marketwatch.comAchieve Life Sciences partners with Omnicom for product launchJune 27, 2025 | msn.comAchieve Life Sciences Teams With Omnicon on Nicotine Dependence TreatmentJune 27, 2025 | marketwatch.comAchieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking CessationJune 27, 2025 | finance.yahoo.comAchieve Life Sciences stock falls after pricing capital raise of $45M via securities offeringJune 27, 2025 | msn.comAchieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public OfferingJune 26, 2025 | globenewswire.comAchieve Life Sciences Announces Proposed Underwritten Public OfferingJune 26, 2025 | globenewswire.comAchieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two DecadesJune 26, 2025 | globenewswire.comAchieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200 Day Moving Average - Time to Sell?June 25, 2025 | marketbeat.comACHV Achieve Life Sciences, Inc. - Seeking AlphaJune 24, 2025 | seekingalpha.comachieve life sciences holds annual meeting with key votesJune 7, 2025 | investing.comAchieve Life Sciences (NASDAQ:ACHV) Shares Pass Above 200 Day Moving Average - What's Next?June 5, 2025 | marketbeat.comAchieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies RiskJune 3, 2025 | seekingalpha.comAchieve Life Sciences to Present at the Jefferies Global Healthcare ConferenceMay 28, 2025 | globenewswire.comAchieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine IntakeMay 20, 2025 | globenewswire.comShay Capital LLC Sells 425,000 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV)May 19, 2025 | marketbeat.comEarnings call transcript: Achieve Life Sciences Q1 2025 targets nicotine dependence marketMay 14, 2025 | investing.comAchieve Life Sciences, Inc. Confirms NDA Submission for Cytisinicline to FDA in June 2025 and Reports Q1 2025 Financial ResultsMay 14, 2025 | nasdaq.comACHV: Kicking Butts to Achieve June NDA FilingMay 14, 2025 | finance.yahoo.comAchieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2025 Earnings Call TranscriptMay 14, 2025 | msn.comAchieve Life Sciences Inc (ACHV) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ...May 14, 2025 | uk.finance.yahoo.comAchieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline ProgramMay 13, 2025 | globenewswire.comRaymond James Financial Inc. Takes $554,000 Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV)May 11, 2025 | marketbeat.comAchieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025May 6, 2025 | globenewswire.comAchieve Life Sciences (ACHV) Expected to Announce Quarterly Earnings on ThursdayMay 3, 2025 | marketbeat.comAchieve Life Sciences Reports Positive Results from ORCA-3 Trial of Cytisinicline for Smoking CessationApril 23, 2025 | nasdaq.comAchieve Life Sciences announces publication of results from Phase 3 ORCA-3 trialApril 22, 2025 | finance.yahoo.comAchieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal MedicineApril 21, 2025 | globenewswire.comRaymond James Financial Inc. Invests $554,000 in Achieve Life Sciences, Inc. (NASDAQ:ACHV)April 9, 2025 | marketbeat.comJonesTrading Keeps Their Buy Rating on Achieve Life Sciences (ACHV)April 2, 2025 | markets.businessinsider.comD-Wave Claims to Achieve ‘Quantum Supremacy’ — Some Researchers DisagreeMarch 30, 2025 | techrepublic.comTAchieve Life Sciences, Inc. (ACHV): A Bull Case TheoryMarch 20, 2025 | insidermonkey.comInsider Buying: Achieve Life Sciences, Inc. (NASDAQ:ACHV) CFO Purchases 10,000 Shares of StockMarch 20, 2025 | marketbeat.comAchieve Life Sciences, Inc. (NASDAQ:ACHV) CFO Purchases $28,900.00 in StockMarch 20, 2025 | insidertrades.comACHV: 2Q:25 NDA SubmissionMarch 12, 2025 | msn.comAchieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2024 Earnings Call TranscriptMarch 12, 2025 | insidermonkey.comAchieve Life Sciences (NASDAQ:ACHV) Announces Earnings ResultsMarch 12, 2025 | marketbeat.comLake Street Keeps Their Buy Rating on Achieve Life Sciences (ACHV)March 11, 2025 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Achieve Life Sciences (ACHV), Dexcom (DXCM)March 11, 2025 | markets.businessinsider.comAchieve Life Sciences, Inc. (ACHV) Q4 2024 Earnings Call TranscriptMarch 11, 2025 | seekingalpha.comAchieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development ProgramMarch 11, 2025 | globenewswire.comAchieve Life Sciences (ACHV) Projected to Post Earnings on TuesdayMarch 10, 2025 | marketbeat.com Get Achieve Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter. Email Address ACHV Media Mentions By Week ACHV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACHV News Sentiment▼0.000.57▲Average Medical News Sentiment ACHV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACHV Articles This Week▼03▲ACHV Articles Average Week Get Achieve Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RIGL News XOMA News VNDA News VSTM News CDXS News CBIO News AGEN News IRWD News SGMO News DOMH News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACHV) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achieve Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Achieve Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.